Fig. 3From: Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastomaIn vivo persistence of GD2-specific 4SCAR-T cells in peripheral blood. The copy number of GD2-specific 4SCAR-T cells in peripheral blood of indicated patients was determined by RT-qPCR analysisBack to article page